2 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
tablet once daily ... increase to 500 mcg ... recommendations for the treatment ... the use of this medication ... won’t have any clinical
Behçet's Syndrome
Systemic disease associated with inflammation of multiple organs, small-vessel vasculitis and large-vessel vasculopathy
Epidemiology:
 • Young
association • M > F Clinical ... matter, spinal cord ... coronary artery aneurysms ... Arthritis, AS Treatment ... • Nonsurgical abdominal